Ye, Fang
Yin, Yi
Wang, Jiexiao
Wang, Jialiang
Yang, Jie
Zhang, Jun
Zhang, Yani
Qi, Jian
Zhu, Qizhi
Zhang, Yucheng
Ji, Haifen
Hu, Zongtao
Hong, Bo
Wang, Hongzhi
Funding for this research was provided by:
the Program of Clinical Medical Translational Research in Anhui Province (202304295107020092)
the National Natural Science Foundation of China (81872438)
the Collaborative Innovation Program of Hefei Science Center, CAS (2022HSC-CIP015)
Program of Research and Development of Key Common Technologies and Engineering of Major Scientific and Technological Achievements in Hefei (2021YL007)
Article History
Received: 11 November 2025
Accepted: 5 February 2026
First Online: 11 February 2026
Declarations
:
: The authors declare no competing interests.
: The study was approved by The Ethics Committee of Hefei Cancer Hospital of the Chinese Academy of Sciences, with the approval number SL-PJ2023-098.
: All clinical samples and information were obtained with written informed consent of the patients.
: Not applicable.